Keyphrases
Liver Transplantation
100%
Cirrhosis
63%
Morbid Obesity
49%
Liver
49%
Weight Loss
45%
Alcoholic Hepatitis
41%
Morbidly Obese Patients
41%
Liver Transplant Recipients
40%
Decompensated Cirrhosis
33%
Hepatocellular Carcinoma
31%
Bariatric Surgery
27%
Hepatitis C Virus
23%
Bacterial Infection
22%
Hepatitis
22%
Orthotopic Liver Transplantation
21%
Large-volume Paracentesis
20%
Refractory Ascites
20%
Primary Biliary Cholangitis
20%
Acute-on-chronic Liver Failure
20%
Gastric Bypass
20%
Hepatitis B Virus
19%
Obese Patients
19%
Comorbidity
19%
Liver Disease
18%
Non-alcoholic Fatty Liver Disease (NAFLD)
18%
Transplantation
18%
MELD Score
17%
C-reactive Protein
17%
Alfapump
17%
Leptin
16%
Hepatic Encephalopathy
16%
Liver Biopsy
15%
Cognitive Function
15%
After Surgery
14%
Adult Patients
13%
Multicenter Cohort Study
13%
Multicenter Randomized Controlled Trial
13%
Capillary
13%
Lipoprotein Lipase
13%
Spontaneous Bacterial Peritonitis
13%
Occult Hepatitis B Infection
13%
Cytomegalovirus Disease
13%
Transjugular Intrahepatic Portosystemic Shunt
13%
Obeticholic Acid
13%
Risk Factors
13%
Plasminogen Activator inhibitor-1 (PAI-1)
13%
Interleukin-6
13%
Magnetic Resonance
12%
Anti-HBc
12%
Corticospinal Tract
12%
Medicine and Dentistry
Liver Cirrhosis
67%
Liver Transplantation
67%
Liver Graft
29%
Hepatic Encephalopathy
29%
Hepatocellular Carcinoma
26%
Ascites
22%
Paracentesis
20%
Alcohol Liver Disease
20%
Bacterial Infection
20%
Infection
20%
Comorbidity
19%
Acute on Chronic Liver Failure
18%
Gastric Bypass Surgery
17%
Bariatric Surgery
17%
Quality of Life
17%
Decompensated Liver Cirrhosis
16%
Liver Disease
16%
Cytomegalovirus Infection
16%
Fatty Liver
14%
Cognition
13%
Hepatitis C Virus
13%
Cohort Analysis
13%
Primary Biliary Cirrhosis
13%
Capillary
13%
Hepatitis B
13%
Chronic Liver Disease
13%
Hepatitis B Virus
13%
Prevalence
12%
Biopsy Technique
12%
Recurrent Disease
12%
Leptin
11%
Nonalcoholic Fatty Liver
11%
Gastric Bypass
11%
Edema
10%
Maturity Onset Diabetes of the Young
10%
Surgery
10%
Neoplasm
10%
Morbid Obesity
10%
Body Mass Index
10%
Model for End-Stage Liver Disease
9%
Steatosis
9%
Dyslipidemia
9%
Satiety
9%
Human Immunodeficiency Virus
9%
Brain Edema
9%
Pathophysiology
9%
Diseases
9%
Retransplantation
8%
Prospective Study
8%
Transjugular Intrahepatic Portosystemic Shunt
8%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cirrhosis
67%
Infection
38%
Decompensated Liver Cirrhosis
33%
Alcohol Liver Disease
27%
Liver Disease
26%
Bacterial Infection
26%
Hepatitis B Virus
24%
Hepatic Encephalopathy
24%
Ascites
22%
Primary Biliary Cirrhosis
22%
Hepatitis B
22%
Ethanol
22%
Hepatitis C Virus
19%
Acute on Chronic Liver Failure
18%
Liver Cell Carcinoma
18%
Prospective Study
17%
Comorbidity
16%
Inflammation
15%
Hepatitis C
15%
Pancreatic Lipase
15%
Fatty Liver
14%
End Stage Liver Disease
13%
C Reactive Protein
13%
Lipoprotein Lipase
13%
Bacterial Peritonitis
13%
Recurrent Disease
13%
Obeticholic Acid
13%
Prevalence
13%
Hepatitis B Core Antibody
12%
Chronic Hepatitis
11%
Fibrinogen
11%
Antibiotics
11%
Disease
10%
Hepatitis B Antigen
10%
Biological Marker
10%
Morbid Obesity
10%
Bilirubin
9%
Interleukin 6
9%
Tumor Necrosis Factor
9%
Cytomegalovirus Infection
9%
Cohort Study
9%
Cognitive Defect
8%
Virus DNA
8%
Liver Triacylglycerol Lipase
8%
Replacement Therapy
8%
Leptin
8%
HIV
8%
Pathophysiology
8%
Hospital Mortality
7%
Steatosis
7%